Growth hormone alleviates oxidative stress and improves the IVF outcomes of poor ovarian responders: a randomized controlled trial

被引：0
|
作者：
Yan Gong
Kun Zhang
Dongsheng Xiong
Jiajing Wei
Hao Tan
Shengfang Qin
机构：
[1] The Affiliated Women’s and children’s Hospital of Chengdu Medical College,Reproductive Medicine Centre, Sichuan Provincial Women’s and Children’s Hospital
[2] Chengdu Medical College,Department of Genetics, School of Bioscience and Technology
[3] The Affiliated Women’s and children’s Hospital of Chengdu Medical College,Department of Medical Genetics and Prenatal Diagnosis, Sichuan Provincial Women’s and Children’s Hospital
来源：
Reproductive Biology and Endocrinology | / 18卷
关键词：
Poor ovarian response; In vitro fertilization; Growth hormone; Oxidative stress; Reactive oxygen species;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] A randomized, controlled, pilot trial on the effect of dehydroepiandrosterone on ovarian response markers, ovarian response, and in vitro fertilization outcomes in poor responders
    Yeung, Tracy Wing Yee
    Chai, Joyce
    Li, Raymond Hang Wun
    Lee, Vivian Chi Yan
    Ho, Pak Chung
    Ng, Ernest Hung Yu
    FERTILITY AND STERILITY, 2014, 102 (01) : 108 - +
  • [22] ANDRO-IVF: a novel protocol for poor responders to IVF controlled ovarian stimulation
    Bercaire, Ludmila
    Nogueira, Sara M. B.
    Lima, Priscila C. M.
    Alves, Vanessa R.
    Donadio, Nilka
    Dzik, Artur
    Cavagna, Mario
    Fanchin, Renato
    JORNAL BRASILEIRO DE REPRODUCAO ASSISTIDA, 2018, 22 (01): : 52 - 55
  • [23] Aromatase inhibitors improve IVF outcomes in poor responders: A randomized controlled pilot study.
    Kashyap, S
    Wells, G
    Davis, O
    Williams-Pittman, MA
    Rosenwaks, Z
    JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 2005, 12 (02) : 310A - 311A
  • [24] Results of the ESPART randomized controlled trial investigating recombinant luteinizing hormone supplementation for controlled ovarian stimulation in poor ovarian responders aligned with the Bologna criteria
    Humaidan, P.
    Chin, W.
    Rogoff, D.
    HUMAN REPRODUCTION, 2016, 31 : 15 - 16
  • [25] Which is the best IVF/ICSI protocol to be used in poor responders receiving growth hormone as an adjuvant treatment? A prospective randomized trial
    Dakhly, Dina M. R.
    Bayoumi, Yomna A.
    Allah, Sherine H. Gad
    GYNECOLOGICAL ENDOCRINOLOGY, 2016, 32 (02) : 116 - 119
  • [26] Does the addition of growth hormone to the in vitro fertilization/intracytoplasmic sperm injection antagonist protocol improve outcomes in poor responders? A randomized, controlled trial
    Bassiouny, Yasmin Ahmed
    Dakhly, Dina Mohamed Refaat
    Bayoumi, Yomna Ali
    Hashish, Nawara Mohamed
    FERTILITY AND STERILITY, 2016, 105 (03) : 697 - 702
  • [27] Response to Letter to Editor regarding Growth hormone supplementation during ovarian stimulation improves oocyte and embryo outcomes in IVF/PGT-A cycles of women who are not poor responders
    Amanda Skillern
    Winifred Mak
    Journal of Assisted Reproduction and Genetics, 2021, 38 : 1887 - 1888
  • [28] Response to Letter to Editor regarding Growth hormone supplementation during ovarian stimulation improves oocyte and embryo outcomes in IVF/PGT-A cycles of women who are not poor responders
    Skillern, Amanda
    Mak, Winifred
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2021, 38 (07) : 1887 - 1888
  • [29] The value of growth hormone supplements in ART for poor ovarian responders
    de Ziegler, Dominique
    Streuli, Isabelle
    Meldrum, David R.
    Chapron, Charles
    FERTILITY AND STERILITY, 2011, 96 (05) : 1069 - 1076
  • [30] Testosterone priming (short or long course) before IVF does not improve the number of oocytes retrieved in poor ovarian responders: a randomized controlled trial
    Subira, I.
    Algaba, A.
    Vazquez, S.
    Taroncher Dasi, R.
    Month Fabuel, S.
    Baydal, V.
    Ruiz Herreros, A.
    Garcia Camunas, N.
    Rubio Rubio, J. M.
    HUMAN REPRODUCTION, 2020, 35 : 7 - 7
12345